Partnerships Licensing Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2015


#430606

138pages

GlobalData

$ 1500

In Stock

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2015

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q2 2015 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q2 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the five quarters.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q2 2015 15
2.1 Pharmaceuticals & Healthcare, Global, M&A, Q2 2015 15
2.1.1 Top M&A Deals in Q2 2015 16
2.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q2 2014 - Q2 2015 17
2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q2 2015 19
2.2.1 Top Initial Public Offerings in Q2 2015 20
2.2.2 Top Secondary Offerings in Q2 2015 21
2.2.3 Top PIPE Deals in Q2 2015 21
2.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q2 2014-Q2 2015 22
2.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q2 2014 - Q2 2015 22
2.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q2 2015 24
2.3.1 Top Venture Financing Deals in Q2 2015 25
2.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2015 26
2.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2015 27
2.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q2 2014 - Q2 2015 28
2.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q2 2014 - Q2 2015 29
2.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q2 2014 - Q2 2015 30
2.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q2 2015 31
2.4.1 Top Private Equity Deals in Q2 2015 32
2.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q2 2014 - Q2 2015 33
3 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2015 34
3.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2015 34
3.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q2 2014 - Q2 2015 36
3.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2015 38
3.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q2 2015 39
3.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2015 40
3.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q2 2015 41
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 42
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q2 2014 - Q2 2015 44
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q2 2014 - Q2 2015 45
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 47
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q2 2015 49
4.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q2 2015 49
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 51
4.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q2 2015 52
4.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q2 2015 53
4.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q2 2015 54
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q2 2014 - Q2 2015 55
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q2 2014 - Q2 2015 57
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2014 - Q2 2015 59
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2014 - Q2 2015 60
4.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q2 2014 - Q2 2015 62
5 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 64
5.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q2 2014 - Q2 2015 64
5.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q2 2014 - Q2 2015 66
5.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q2 2014 - Q2 2015 67
5.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q2 2014 - Q2 2015 69
5.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q2 2014 - Q2 2015 71
5.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q2 2014 - Q2 2015 73
5.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q2 2014 - Q2 2015 75
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 77
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q2 2015 77
6.1.1 Oncology - Deals of the Quarter 79
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q2 2015 81
6.2.1 Central Nervous System - Deals of the Quarter 82
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q2 2015 84
6.3.1 Infectious Disease - Deals of the Quarter 85
6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q2 2015 88
6.4.1 Immunology - Deals of the Quarter 89
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q2 2015 91
6.5.1 Metabolic Disorders - Deals of the Quarter 93
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q2 2015 95
6.6.1 Cardiovascular - Deals of the Quarter 96
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q2 2015 98
6.7.1 Gastrointestinal - Deals of the Quarter 99
6.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q2 2015 102
6.8.1 Dermatology - Deals of the Quarter 103
6.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q2 2015 105
6.9.1 Respiratory - Deals of the Quarter 106
6.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q2 2015 108
6.10.1 Ophthalmology - Deals of the Quarter 109
7 Deal Summary by Geography 111
7.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q2 2015 111
7.1.1 North America - Deals of the Quarter 113
7.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q2 2015 118
7.2.1 Europe - Deals of the Quarter 120
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q2 2015 122
7.3.1 Asia-Pacific - Deals of the Quarter 124
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q2 2015 126
7.4.1 Rest of the World - Deals of the Quarter 127
8 Pharmaceuticals & Healthcare, Global, Top Advisors 129
8.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q2 2014 - Q2 2015 129
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q2 2014 - Q2 2015 131
9 Appendix 133
10 Further Information 135
10.1 Methodology 135
10.2 About GlobalData 136
10.3 Disclosure information 137
10.4 Disclaimer 137

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 16
Table 2: Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q2 2015 16
Table 3: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q2 2014 - Q2 2015 18
Table 4: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2014 - Q2 2015 20
Table 5: Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q2 2015 20
Table 6: Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q2 2015 21
Table 7: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q2 2015 21
Table 8: Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q2 2014-Q2 2015 22
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2014 - Q2 2015 23
Table 10: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 25
Table 11: Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q2 2015 25
Table 12: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q2 2015 27
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2014 - Q2 2015 28
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 29
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q2 2014 - Q2 2015 30
Table 16: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 32
Table 17: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q2 2015 32
Table 18: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2014 - Q2 2015 33
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 35
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 37
Table 21: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 39
Table 22: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2015 39
Table 23: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2015 40
Table 24: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q2 2015 41
Table 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 43
Table 26: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2014 - Q2 2015 46
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 48
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 50
Table 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 52
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q2 2015 52
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q2 2015 53
Table 32: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q2 2015 54
Table 33: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 56
Table 34: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q2 2014 - Q2 2015 58
Table 35: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2014 - Q2 2015 61
Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 63
Table 37: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value vs Median Deal Value, (US$m), Q2 2014 - Q2 2015 65
Table 38: Pharmaceuticals & Healthcare, Global Acquisitions, Average P/E of Acquired Companies, Q2 2014 - Q2 2015 66
Table 39: Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q2 2014 - Q2 2015 68
Table 40: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Operating Profit, Q2 2014 - Q2 2015 70
Table 41: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Market Price Per Share, Q2 2014 - Q2 2015 72
Table 42: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Book Value Per Share, Q2 2014 - Q2 2015 74
Table 43: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q2 2014 - Q2 2015 76
Table 44: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 78
Table 45: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 82
Table 46: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 85
Table 47: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 89
Table 48: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 92
Table 49: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 96
Table 50: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 99
Table 51: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 103
Table 52: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 106
Table 53: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 109
Table 54: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 112
Table 55: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 119
Table 56: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 123
Table 57: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 127
Table 58: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 130
Table 59: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 132
Table 60: Pharmaceuticals & Healthcare, Deals Key Financials, Global Acquisition Deals, Q2 2014-Q2 2015 133

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q2 2014 - Q2 2015 15
Figure 2: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q2 2014 - Q2 2015 17
Figure 3: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 19
Figure 4: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), , Q2 2014 - Q2 2015 22
Figure 5: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 24
Figure 6: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q2 2015 26
Figure 7: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q2 2015 27
Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q2 2014 - Q2 2015 28
Figure 9: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 29
Figure 10: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 31
Figure 11: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q2 2014 - Q2 2015 33
Figure 12: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 34
Figure 13: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 36
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 38
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 42
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2014 - Q2 2015 44
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2014 - Q2 2015 45
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2014 - Q2 2015 47
Figure 19: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 49
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 51
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 55
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 57
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q2 2014 - Q2 2015 59
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q2 2014 - Q2 2015 60
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2014 - Q2 2015 62
Figure 26: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value vs Median Deal Value, (US$m), Q2 2014 - Q2 2015 64
Figure 27: Pharmaceuticals & Healthcare, Global Acquisitions, Average P/E of Acquired Companies, Q2 2014 - Q2 2015 66
Figure 28: Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q2 2014 - Q2 2015 67
Figure 29: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q2 2014 - Q2 2015 69
Figure 30: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Market Price Per Share, Q2 2014 - Q2 2015 71
Figure 31: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share vs Average Book Value Per Share, Q2 2014 - Q2 2015 73
Figure 32: Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q2 2014 - Q2 2015 75
Figure 33: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 77
Figure 34: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 81
Figure 35: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 84
Figure 36: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 88
Figure 37: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 91
Figure 38: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 95
Figure 39: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 98
Figure 40: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 102
Figure 41: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 105
Figure 42: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 108
Figure 43: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 111
Figure 44: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 118
Figure 45: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 122
Figure 46: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 126
Figure 47: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 129
Figure 48: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q2 2014 - Q2 2015 131